$2.050
-0.010 (-0.49%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PCSA Prediction & Forecast by Similar Chart Analysis
Alphio's PCSA stock price prediction model matches the current Processa Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.03 (-1.17%). The 1-week path is $2.06 (+0.37%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Processa Pharmaceuticals Inc Stock?
Currently, Processa Pharmaceuticals Inc (PCSA) is not a good buy. The stock has dropped 56.19% over the past year and has a low RSI of 31.285, indicating it is oversold. Additionally, the forward P/E ratio is 0, suggesting no earnings growth is expected in the near future. The recent acquisition of Vidya, while potentially beneficial long-term, led to a sharp 38% drop in stock price, highlighting market skepticism. The main risk is the company's negative net income, which stood at -3,265,494 USD in Q2 2026, indicating ongoing financial struggles.
PCSA stock price ended at $2.05 on Monday, after losing -0.49%
Processa Pharmaceuticals Inc (PCSA) last closed at $2.05, losing -0.49%. These facts feed the 1-day and 1-week PCSA price prediction above.
Forecast Drivers
Processa Pharmaceuticals Inc (PCSA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PCSA, ranked by similarity.
Seasonality analysis for PCSA
Historically the probability of a positive September return for PCSA is 0.00%. January offers the highest probability of a positive month at 37.70%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PCSA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $0.20 | $0.24 | $0.26 | -88.21% |
| Oct 2026 | $0.15 | $0.20 | $0.23 | -90.48% |
| Nov 2026 | $0.16 | $0.20 | $0.23 | -90.09% |
| Dec 2026 | $0.18 | $0.21 | $0.24 | -89.68% |
In 2026, Processa Pharmaceuticals Inc (PCSA) is projected to range from $0.15 to $0.26.
Processa Pharmaceuticals Inc 2026 monthly forecast
In Sep 2026, Processa Pharmaceuticals Inc is projected to average $0.24, with a low of $0.20 and high of $0.26.
In Oct 2026, Processa Pharmaceuticals Inc is projected to average $0.20, with a low of $0.15 and high of $0.23.
In Nov 2026, Processa Pharmaceuticals Inc is projected to average $0.20, with a low of $0.16 and high of $0.23.
In Dec 2026, Processa Pharmaceuticals Inc is projected to average $0.21, with a low of $0.18 and high of $0.24.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.